Aurora Cannabis Inc. ACB,
+ 1.10%
ACB,
+ 0.80%
on Thursday filed a potential sale of $ 300 million in fresh stocks, and raised the possibility of an acquisition in the United States. The Canadian cannabis company said it expects a market share offer of $ 300 million while releasing its quarterly results last week, and filed a leaflet with the Securities and Exchange Commission for the sale Thursday. In the prospectus and in a press release announcing the filing, Aurora suggested that the proceeds would be used to find an acquisition target in the US market. “Aurora believes that this deposit will provide maximum flexibility for the company to pursue certain acquisitions in the future, including in the United States,” the company said in his exit. Aurora confirms that its current cash position remains strong at approximately $ 525 million as of May 13, 2021. Given the strength of Aurora’s current cash position, it should not need to access the ATM program without accretive use of the product. ” Aurora agreed to buy an American CBD company last year, but may be looking for a more traditional marijuana asset in the United States, as many states across the country legalize recreational sales of the drug. Canadian companies are not allowed to own cannabis businesses in the United States, as the drug is still federally illegal in the country, but can acquire warrants to own a business if or when the drug is federally decriminalized. . Aurora’s US-listed share was about 1.5% higher before the close on Thursday, after falling nearly 40% in the past three months.